Age-Related Pharmacokinetic Changes

Age-related pharmacokinetic changes are the alterations in how the body absorbs, distributes, metabolises, and eliminates drugs that accompany ageing. As people grow older, reduced kidney and liver function, shifts in body composition, and other physiological changes can raise drug exposure or prolong drug action, even when the prescribed dose is unchanged. These changes are a core reason that medication behaves differently in older adults and contribute to their heightened risk of adverse drug effects.

Definition

Age-related pharmacokinetic changes are the systematic differences, attributable to physiological ageing, in the absorption, distribution, metabolism, and elimination of drugs, which together alter the concentration-time profile of a medicine in older adults relative to younger ones.

Scope

The topic covers the four classical pharmacokinetic processes (absorption, distribution, metabolism, and elimination) and how each is modified by ageing, together with the practical implication that drug exposure for a given dose tends to be higher or more prolonged in older patients. It is a conceptual and reference treatment of geriatric pharmacokinetics and does not provide dosing instructions.

Core questions

• How does ageing affect each of the four pharmacokinetic processes?
• Why does reduced renal and hepatic function matter most for drug exposure in older adults?
• How do changes in body composition alter the distribution of water-soluble and fat-soluble drugs?
• Why can a standard adult dose produce a stronger or longer effect in an older person?

Key concepts

• Absorption
• Distribution
• Volume of distribution
• Metabolism (hepatic clearance)
• Elimination (renal clearance)
• Reduced glomerular filtration with age
• Body composition (fat-to-water ratio)
• Drug half-life
• Plasma protein binding

Mechanisms

With ageing, total body water and lean mass tend to fall while the proportion of body fat rises, which can lower the volume of distribution of water-soluble drugs and raise it for fat-soluble drugs, the latter prolonging their half-life. Hepatic mass and blood flow decline, reducing first-pass and clearance for some metabolised drugs, and renal function commonly falls, slowing the elimination of drugs cleared by the kidney; these changes together tend to increase or prolong drug exposure for a given dose (Mangoni & Jackson, 2003). Absorption is the least consistently affected process. Because exposure rises while physiological reserve declines, the margin between benefit and harm narrows, which helps explain the greater frequency of adverse drug events in older patients (Maher, Hanlon, & Hajjar, 2013).

Clinical relevance

Understanding how ageing changes drug handling explains why older adults are more susceptible to drug accumulation and adverse effects, and why prescribing principles for this group differ from those for younger adults. This entry is educational background on the pharmacology of ageing; it describes general mechanisms and is not a basis for setting or changing any individual's dose.

History

Recognition that drugs behave differently in older adults grew through the second half of the twentieth century as clinical pharmacology matured. Reviews synthesising the physiological basis of these differences, such as Mangoni and Jackson (2003), helped consolidate the four-process framework of absorption, distribution, metabolism, and elimination as the standard way to teach geriatric pharmacokinetics, a structure also presented in general pharmacology texts (Katzung, 2018).

Key figures

• Arduino Mangoni
• Stephen Jackson
• Sarah Hilmer

Seminal works

• mangoni-2003

Frequently asked questions

Which pharmacokinetic process changes most with age?

Elimination is often the most clinically important: renal clearance commonly declines with age, slowing the removal of drugs cleared by the kidney, while hepatic metabolism may also fall. Absorption is the least consistently affected.

Why can the same dose affect an older person more strongly?

Because reduced clearance and altered distribution can raise or prolong drug exposure for a given dose, so a concentration that is safe in a younger adult may be higher or longer-lasting in an older one.